Alcohol increases the expression of type 1, but not type 2 α corticotropin-releasing factor (CRF) receptor messenger ribonucleic acid in the rat hypothalamus

Molecular Brain Research

Volumn 52, Issue 1, 1997, Pages 78-89

  Lee, Soon ^a   Rivier, Catherine ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Alcohol; Corticotropin releasing factor (CRF) receptor; Hypothalamus; Rat

Indexed keywords

ALCOHOL; ASTRESSIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ALCOHOL INTOXICATION; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HYPOTHALAMUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; TRANSCRIPTION REGULATION;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; ETHANOL; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; MALE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER;

EID: 0030781961     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00226-X     Document Type: Article

References (69)

1. Alari L., Lewander T., Sjoquist B. The effect of ethanol on the brain catecholamine systems in female mice, rats, and guinea pigs. Alcoholism Clin. Exp. Res. 11:1987;144-149.
2. Beaulieu J., Drolet G. Origin of the corticotropin-releasing factor immunoreactive innervation of the paraventricular nucleus of the hypothalamus. 24th Annual Meeting of the Society for Neurosciences. 20:1994;645.
3. Beaulieu S., DiPaolo T., Barden N. Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotoninergic system and its relevance to the gulcocorticoid delayed negative feedback mechanism. Neuroendocrinology. 44:1986;247-254.
4. Beaulieu S., DiPaolo T., Cote J., Barden N. Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems. Neuroendocrinology. 45:1987;37-46.
5. Behan D.P., Grigoriadis D.E., Lovenberg T., Chalmers D., Heinrichs S., Liaw C., De Souza E.B. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. Mol. Psychiatry. 1:1996;265-277.
6. Bilezikjian L.M., Vale W.W. Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3′,5′-monophosphate in cultured anterior pituitary cells. Endocrinology. 113:1983;657-662.
7. Cador M., Cole B.J., Koob G.F., Stinus L., LeMoal M. Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine. Brain Res. 606:1992;181-186.
8. Cador M., Dumas S., Cole B.J., Mallet J., Koob G.F., LeMoal M., Stinus L. Behavioral sensitization induced by psychostimulants or stress: search for a molecular basis and evidence for a CRF-dependent phenomenon. Ann. NY Acad. Sci. 654:1992;416-420.
9. 1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
10. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., DeSouza E.B. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17:1996;166-172.
11. Chan R., Sawchenko P. Hemodynamic regulation of tyrosine hydroxylase messenger RNA in medullary catecholamine neurons: a c-fos-guided hybridization histochemical study. Neuroscience. 66:1995;377-390.
12. Chang C., Pearse R., O'Connell S., Rosenfeld M. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron. 11:1993;1187-1195.
13. Chang S.L., Patel N.A., Romero A.A. Activation and desensitization of fos immunoreactivity in the rat brain following ethanol administration. Brain Res. 679:1995;89-98.
14. Chen R., Lewis K., Perrin M., Vale W. Expression cloning of a human corticotropin-releasing factor receptor. Proc. Natl. Acad. Sci. USA. 90:1993;8967-8971.
15. DeSouza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology. 20:1995;789-819.
16. E.B. DeSouza, T.R. Insel, Corticotropin-releasing factor (CRF) receptors in the rat central nervous system: autoradiographic localization studies, in: E.B. DeSouza, C.B. Nemeroff (Eds.), Corticotropin-Releasing Factor: Basic and Clinical Studies Of A Neuropeptide, CRC Press, Boca Raton, FL, 1990, pp. 69-90.
17. DeSouza E.B., Insel T.R., Perrin M.H., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J. Neurosci. 5:1985;3189-3203.
18. Detering N., Collins R.M. Jr., Hawkins R.L., Ozand P.T., Karahasan A. Comparative effects of ethanol and malnutrition on the development of catecholamine neurons: changes in neurotransmitter levels. J. Neurochem. 34:1980;1587-1593.
19. A.J. Dunn, C.W. Berridge, Is corticotropin-releasing factor a mediator of stress responses. Tenth Annual Winter Neuropeptide Conference, Breckenridge, CO - January 16-20, 1989, in: G.F. Koob, C.A. Sandman, F.L. Strand (Eds.), Vol. 579, NY Acad. Sci., New York, 1990, pp. 183-191.
20. Feldman S., Conforti N., Itzik A., Weidenfeld J. Differential effect of amygdaloid lesions on CRF-41, ACTH and corticosterone responses following neural stimuli. Brain Res. 658:1994;21-26.
21. Gaykema R., Dijkstra I., Tilders F. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology. 136:1995;4717-4720.
22. George F.R., Collins A.C. Ethanol's behavioral effects may be partly due to increases in brain prostaglandin production. Alcoholism Clin. Exp. Res. 9:1985;143-146.
23. George S., Fan T., Roldan L., Naranjo C. Corticotropin-releasing factor is altered in brains of animals with high preference for ethanol. Alcoholism Clin. Exp. Res. 14:1990;425-429.
24. Gulyas J., Rivier C., Perrin M., Koerber S., Sutton S., Corrigan A., Lahrichi S., Craig A., Vale W., Rivier J. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor (CRF). Proc. Natl. Acad. Sci. USA. 92:1995;10575-10579.
25. Heinrichs S.C., Menzaghi F., Schulteis G., Koob G.F., Stinus L. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav. Pharmacol. 6:1995;74-80.
26. Imaki T., Naruse M., Harada S., Chikada N., Imaki J., Onodera H., Demura H., Vale W. Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. Mol. Brain Res. 38:1996;166-170.
27. Imaki T., Shibasaki T., Wang X.-Q., Demura H. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress. Neuroendocrinology. 61:1995;445-452.
28. Kapcala L.P., He J.R., Gao Y., Pieper J.O., DeTolla L.J. Subdiaphragmatic vagotomy inhibits intra-abdominal interleukin-1β stimulation of adrenocorticotropin secretion. Brain Res. 728:1996;247-254.
29. Kiss A., Palkovits M., Aguilera G. Neural regulation of corticotropin releasing hormone (CRH) an dCRH receptor mRNA in the hypothalamic paraventricular nucleus in the rat. J. Neuroendocrinol. 8:1996;103-112.
30. Koob G. Drug addiction: the Yin and Yang of hedonic homeostasis. Neuron. 16:1996;893-896.
31. G. Koob, S. Rassnick, F. Manzaghi, F. Weiss, Alcohol, the reward system and dependence, in: L. Terenius, B. Vallee (Eds.), Toward A Molecular Basis Of Alcohol Use And Abuse, Birkhauser-Verlag, Boston, MA, 1994, pp. 103-114.
32. G.F. Koob, S.C. Heinrichs, E.M. Pich, F. Menzaghi, H. Baldwin, K. Miczek, K.T. Britton, The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Foundtaion Symposium No. 172 on Corticotroin-Releasing Factor, London, March 10-12, 1992, in: D.J. Chadwick, J. Marsh, K. Ackrill (Eds.), Corticotropin-Releasing Factor, John Wiley & Sons, New York, 1993, pp. 277-295.
33. Kornreich W.D., Galyean R., Hernandez J.-F., Craig A.G., Donaldson C.J., Yamamoto G., Rivier C., Vale W., Rivier J. Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study. J. Med. Chem. 35:1992;1870-1876.
34. Lacroix S., Rivest S. Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain. J. Chem. Neuroanat. 10:1996;53-71.
35. Lacroix S., Vallières L., Rivest S. C-fos mRNA pattern and CRF neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type. J. Neuroimmunol. 70:1996;163-179.
36. Lovenberg T., Liaw C., Grigoriadis D., Clevenger W., Chalmers D., Souza E.D., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA. 92:1995;836-840.
37. Luo X., Kiss A., Makara G., Lolait S.J., Aguilera G. Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J. Neuroendocrinol. 6:1994;689-696.
38. Luo X., Kiss A., Rabadan-Diehl C., Aguilera G. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids. Endocrinology. 136:1995;3877-3883.
39. Maecker H., Desai A., Dash R., Rivier J., Vale W., Sapolsky R. Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure. Brain Res. 744:1997;166-170.
40. Makino S., Gold P.W., Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res. 640:1994;105-112.
41. Makino S., Schulkin J., Smith M.A., Pacak K., Palkovits M., Gold P.W. Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology. 136:1995;4517-4525.
42. Mansi J.A., Rivest S., Drolet G. Regulation of corticotropin-releasing factor Type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. Endocrinology. 137:1996;4619-4629.
43. V. Martinez, J. Rivier, Y. Taché, Blockade of stress-related alterations of gastrointestinal function by a potent corticotropin-releasing factor (CRF) antagonist: astressin, Annual Meeting of the American Gastroenterol Association, 1996.
44. Martínez V., Rivier J., Wang L., Taché Y. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF-and stress-related alterations of gastric and colonic motor function. J. Pharmacol. Exp. Ther. 280:1997;754-760.
45. Menzaghi F., Rassnick S., Heinrichs S., Baldwin H., Pich E., Weiss F., Koob G. The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann. NY Acad. Sci. 739:1994;176-184.
46. Nappi R., Rivest S. Stress-induced genetic expression of a selective corticotropin-releasing factor-receptor subtype within the rat ovaries: an effect dependent on the ovulatory cycle. Biol. Reprod. 53:1995;1417-1428.
47. Nappi R.E., Rivest S. Ovulatory cycle influences the stimulatory effect of stress on the expression of corticotropin-releasing factor receptor messenger ribonucleic acid in the paraventricular nucleus of the female rat hypothalamus. Endocrinology. 136:1995;4073-4083.
48. K. Ogilvie, C. Rivier, Effect of three different modes of alcohol administration on the activity of the rat hypothalamic-pituitary-adrenal axis, Alcoholism Clin. Exp. Res. (1997) in press.
49. Parkes D., Rivest S., Lee S., Rivier C., Vale W. Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus. Mol. Endocrinol. 7:1994;1357-1367.
50. Pich E.M., Lorang M., Yeganeh M., Fonseca F.D., Raber J., Koob G., Weiss F. Increase in extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15:1995;5439-5447.
51. Pohorecky L.A., Brick J. Pharmacology of ethanol. Pharmacol. Ther. 36:1988;335-427.
52. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P., Vale W. Distribution of CRF receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. USA. 91:1994;8777-8781.
53. Richard D., Rivest R., Naimi N., Timofeeva E., Rivest S. Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology. 137:1996;4786-4795.
54. Rivest S., Laflamme N., Nappi R. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J. Neurosci. 15:1995;2680-2695.
55. Rivest S., Rivier C. Lesions of the hypothalamic PVN partially attenuate the stimulatory action of alcohol on ACTH secretion in the rat. Am. J. Physiol. 266:1994;R553-R558.
56. Rivest S., Rivier C. The role of corticotropin-releasing factor and interleukin-1 in the regulation of neurons controlling reproductive functions. Endocr. Rev. 16:1995;177-199.
57. Rivier C. Alcohol stimulates ACTH secretion in the rat: mechanisms of action and interactions with other stimuli. Alcoholism Clin. Exp. Res. 20:1996;240-254.
58. Rivier C., Bruhn T., Vale W. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J. Pharmacol. Exp. Ther. 229:1984;127-131.
59. Rivier C., Lee S. Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin. Brain Res. 726:1996;1-10.
60. Sehic E., Blatteis C.M. Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pigs. Brain Res. 726:1996;160-166.
61. Selim M., Bradberry C.W. Effect of ethanol on extracellular 5-HT and glutamate in the nucleus accumbens and prefrontal cortex: comparison between the Lewis and Fischer 344 rat strains. Brain Res. 716:1996;157-164.
62. Silverman A.J., Hou-Yu A., Chen W.P. Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus. Neuroendocrinology. 49:1989;291-299.
63. Simmons D.M., Arriza J.L., Swanson L.W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radio-labeled single-stranded RNA probes. J. Histotechnol. 12:1989;169-181.
64. M. Spina, F. Menzaghi, V. Risborough, K. Britton, E. Merlo-Pich, J. Rivier, W. Vale, G. Koob, The behavioral effect of central administration of the novel CRF antagonist astressin, Society for Neuroscience, 25th Annual Meeting, San Diego, CA, Vol. 21, Part 1, November 11-16, 1995, pp. 756.
65. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin releasing factor (CRF)-immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 36:1983;165-186.
66. W. Vale, C. Rivier, P. Plotsky, M. Brown, T. Bruhn, A. Lim, L. Bilezikjian, M. Perrin, M. Chen, P. Sawchenko, L. Swanson, L. Fisher, J. Spiess, J. Rivier, Diverse actions of corticotropin releasing factor, 58th Japanese Endocrinological Society Meeting, Nagoya, Japan, May 14-16, 1985.
67. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β-endorphin. Science. 213:1981;1394-1397.
68. Vaughan J., Donaldson C., Bittencourt J., Perrin M., Lewis K., Sutton S., Chan R., Turnbull A., Lovejoy D., Rivier C., Rivier J., Sawchenko P., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
69. Yoshimoto K., McBride W.J., Lumeng L., Li T.-K. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol. 9:1991;17-22.